The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancer

Leptomeningeal metastasis (LM) is a terminal event in the development of non-small cell lung cancer (NSCLC). It has a poor prognosis with median survival of 1.9 months if untreated. The improvement of OS in NSCLC patients relatively increases incidence of LM. While current therapeutic options for LM...

Descripción completa

Detalles Bibliográficos
Autores principales: Yufen, Xu, Binbin, Song, Wenyu, Chen, Jialiang, Liu, Xinmei, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972805/
https://www.ncbi.nlm.nih.gov/pubmed/27536527
http://dx.doi.org/10.1186/s40064-016-2873-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972805/
https://www.ncbi.nlm.nih.gov/pubmed/27536527
http://dx.doi.org/10.1186/s40064-016-2873-2

Ejemplares similares